The recent detection of H5N1 highly pathogenic avian influenza (HPAI) in New Zealand has exposed a critical gap in insurance coverage, highlighting the need for a comprehensive approach to managing this emerging threat. This article delves into the structural insurance coverage gaps exposed by the H5N1 detection, the implications for the insurance industry, and the broader implications for New Zealand's economy and biosecurity.
The GIA Framework and its Limitations
New Zealand's Government Industry Agreement (GIA) operational agreement, signed in August 2025, sets the cost-sharing architecture for H5N1 responses. While it covers 40% of response costs for H5N1 HPAI, including diagnostics, communications, and disease-control activities, it falls short in addressing consequential losses. The H7N6 outbreak in December 2024, which resulted in significant economic disruption, underscores this gap. The direct cost of that outbreak was estimated at $25 million, with the government approving $20 million in additional funding. However, the revenue losses incurred due to movement controls on uninfected linked farms were not covered by the GIA framework, leaving these losses unaccounted for.
The Severity of H5N1 Risk
H5N1 carries a structurally more severe risk profile than H7N6. Overseas experience suggests that if H5N1 becomes widespread in wild birds, eradication is unlikely. This realization significantly impacts financial models built around the H7N6 precedent. The potential for widespread H5N1 outbreaks poses a greater challenge for the insurance industry, as it may struggle to provide adequate coverage for consequential losses.
Private Insurance Market Limitations
Broker Lockton has published guidance on the structural limitation of the private market's response to bird flu. Bird flu cover is limited and not readily available in all regions due to the severity of potential losses. Cover is often sub-limited, providing only a proportion of the full limit, and becomes severely restricted once an outbreak occurs. Lockton advises producers to secure protection before the virus reaches their region, a crucial recommendation given the recent detection in New Zealand.
Broader Implications and Sectoral Exposure
The H5N1 detection in New Zealand has broader implications for the country's economy and biosecurity. The poultry industry, which generates an estimated $2.2 billion in annual domestic revenue and $200 million in export revenue, is particularly vulnerable. The regulatory cost layer, including proposed regulations for commercial poultry operators, will further impact the risk profile of the sector. These regulations, which require formal avian biosecurity control programs and partial cost recovery for audits, may cause some operators to exit the industry.
The Role of Insurance Regulators
The Insurance Council of New Zealand (ICNZ) has not yet issued specific guidance on avian influenza. While its 2025 annual review acknowledges the growing interconnected risks in New Zealand, its current focus remains on climate and natural hazard resilience. The industry body has yet to publicly address the biosecurity risk posed by H5N1, which has now been confirmed in New Zealand's wild bird population.
Conclusion and Future Considerations
The detection of H5N1 in New Zealand has exposed structural insurance coverage gaps and highlighted the need for a comprehensive approach to managing this emerging threat. The insurance industry must adapt to the changing risk landscape, and regulators should provide guidance and support to address the gaps in coverage. As New Zealand grapples with the potential impact of H5N1, the country must also consider broader implications for its economy and biosecurity, ensuring a coordinated response to this complex challenge.
